A KCR1 variant implicated in susceptibility to the long QT syndrome.

[1]  M. Horie,et al.  Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome , 2009, Circulation. Arrhythmia and electrophysiology.

[2]  P. C. Viswanathan,et al.  HERG Is Protected from Pharmacological Block by α-1,2-Glucosyltransferase Function* , 2007, Journal of Biological Chemistry.

[3]  D. Roden.  Long QT syndrome: reduced repolarization reserve and the genetic link , 2006, Journal of internal medicine.

[4]  P. C. Viswanathan,et al.  Genetics of acquired long QT syndrome. , 2005, The Journal of clinical investigation.

[5]  Dan M Roden,et al.  In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Hayashi,et al.  Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG. , 2004, Clinical science.

[7]  G. Breithardt,et al.  Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients , 2004, Journal of Molecular Medicine.

[8]  D. Roden,et al.  IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Rebecca A. Ayers,et al.  Interaction with GM130 during HERG Ion Channel Trafficking , 2002, The Journal of Biological Chemistry.

[10]  M. Horie,et al.  Drug-Induced Long-QT Syndrome Associated With a Subclinical SCN5A Mutation , 2002, Circulation.

[11]  D. Roden,et al.  Defective Human Ether-à-go-go-related Gene Trafficking Linked to an Endoplasmic Reticulum Retention Signal in the C Terminus* , 2002, The Journal of Biological Chemistry.

[12]  P. C. Viswanathan,et al.  Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes , 2002, Circulation.

[13]  T. McDonald,et al.  14‐3‐3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity , 2002, The EMBO journal.

[14]  Stanley Nattel,et al.  A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? , 2002, The Journal of physiology.

[15]  S. Priori,et al.  Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias , 2000, Journal of cardiovascular electrophysiology.

[16]  M. Keating,et al.  MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.

[17]  D. Roden,et al.  A K+ Channel Splice Variant Common in Human Heart Lacks a C-terminal Domain Required for Expression of Rapidly Activating Delayed Rectifier Current* , 1998, The Journal of Biological Chemistry.

[18]  Hiroto Takahashi,et al.  KCR1, a Membrane Protein That Facilitates Functional Expression of Non-inactivating K+ Currents Associates with Rat EAG Voltage-dependent K+Channels* , 1998, The Journal of Biological Chemistry.

[19]  M. Aebi,et al.  The ALG10 locus of Saccharomyces cerevisiae encodes the alpha-1,2 glucosyltransferase of the endoplasmic reticulum: the terminal glucose of the lipid-linked oligosaccharide is required for efficient N-linked glycosylation. , 1998, Glycobiology.

[20]  D. Roden.  Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes , 1998, Pacing and clinical electrophysiology : PACE.

[21]  P. Coumel,et al.  KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. , 1997, Circulation.

[22]  D. Roden,et al.  Normalization of acquired QT prolongation in humans by intravenous potassium. , 1997, Circulation.

[23]  Glenn I. Fishman,et al.  A minK–HERG complex regulates the cardiac potassium current IKr , 1997, Nature.

[24]  J. Mason,et al.  Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. , 1996, Circulation.

[25]  D. Snyders,et al.  High affinity open channel block by dofetilide of HERG expressed in a human cell line. , 1996, Molecular pharmacology.

[26]  D. Roden,et al.  Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.

[27]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[28]  R. Müller,et al.  Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. , 1995, Gene.

[29]  M. Sanguinetti,et al.  Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents , 1992, Pflügers Archiv.

[30]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.